# Sodium Oxybate in Schizophrenia With Insomnia

> **NCT00594256** · PHASE2 · COMPLETED · sponsor: **Nathan Kline Institute for Psychiatric Research** · enrollment: 8 (actual)

## Conditions studied

- Schizophrenia
- Insomnia Related to Schizophrenia (307.42)

## Interventions

- **DRUG:** Sodium Oxybate

## Key facts

- **NCT ID:** NCT00594256
- **Lead sponsor:** Nathan Kline Institute for Psychiatric Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00594256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00594256, "Sodium Oxybate in Schizophrenia With Insomnia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00594256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*